Ipsen S.A. (EPA:IPN)
103.70
+1.40 (1.37%)
May 30, 2025, 5:35 PM CET
Revenue by Product
Fiscal year is January - December.
Year Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | NaN - NaN |
---|---|---|---|---|---|---|
Oncology | 2.35B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Oncology Growth | -1.19% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Neurosciences | 659.30M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Neurosciences Growth | 9.08% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rare Diseases | 116.90M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rare Diseases Growth | 184.43% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Specialty Medicine | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Specialty Medicine Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Family Health | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Family Health Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Year Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | NaN - NaN |
---|---|---|---|---|---|---|
Europe | 1.26B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe Growth | 1.56% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
North America | 1.04B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
North America Growth | 0.94% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rest of the World | 829.10M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Rest of the World Growth | 9.73% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
France | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
France Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Europe | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Europe Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Eastern Europe | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Eastern Europe Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Germany | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Germany Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Italy | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Italy Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Spain | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Spain Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United Kingdom | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|